Milrinone Lactate Injection, Solution
Product Images NDC 55150-288

100 mL Single Dose Flexible Container of Milrinone Lactate in 5% Dextrose Injection is a sterile solution that is intended for Intravenous Infusion Only. Each 100 mL container contains 20 mg Milrinone Lactate, with a concentration of 200 ug/mL (0.2 mg/mL). The solution is formulated with Milrinone Lactate USP, lactic acid, dextrose, and water for injection, USP. It does not contain any preservatives and is nonpyrogenic. The recommended storage condition is at room temperature not exceeding 25°C (77°F), and it should be protected from freezing and excessive heat. It is distributed by AuroMedics Pharma LLC, and made in India. A physician should direct the administration of the solution intravenously, and package insert should be observed. Check for minute leaks and discard if found, as sterility may be impaired. Also, it is not to be used in series connections, nor should it be administered simultaneously with blood. The solution should be used only if it is clear, colorless to pale yellow.*

This is a description of Milrinone Lactate in 5% Dextrose Injection. It is a sterile, nonpyrogenic, single-dose container for intravenous infusion only, and it contains 20 mg per 100 mL. The usual dosage information can be found in the package insert. The bag should be checked for leaks after removing the overwrap, and it should not be used in series connections or simultaneously with blood. It should be stored at room temperature and not exposed to excessive heat or freezing. The product is distributed by AuroMedics Pharma LLC and was made in India.*

Milrinone lactate in 5% dextrose injection is a sterile solution for intravenous infusion only, with a strength of 20 mg per 100 mL, and packaged in 10 x 100 mL single-dose flexible containers. Each milliliter of the solution contains 0.285 mg of milrinone lactate equivalent to 0.2 mg milrinone USP, 0.262 mL of lactic acid, 543 mg of dextrose hydrous, USP in water for injection, USP. The pH is adjusted with lactic acid and/or sodium hydroxide to pH 3.5 (32 104.0). The product must not be used in series connections and should not be administered simultaneously with blood. The recommended dosage should be checked in the package insert. The product should be stored at room temperature, protected from freezing and excessive heat. If the overwrap has been previously opened or damaged, do not use. Not available.*

This is a sterile 200 mL single dose flexible container containing Milrinone Lactate el in 5% Dextrose Injection with 40 mg per 200 mL. It is for intravenous infusion only and each mL contains 0.285 mg milrinone lactate. The solution is clear, colorless to pale yellow and no preservative is added. It must not be used in series connections and caution should be taken to check for minute leaks. The product is distributed by AuroMedics Pharma LLC and has a recommended storage temperature of 25°C, and the product should be protected from freezing or excessive heat. The package insert should be reviewed for instructions on dosage and administration.*

This is a description of a medication called Milrinone Lactate in 5% Dextrose Injection, which comes in a single-dose flexible container of 200 mL. The medication is used for intravenous infusion only and contains 40 mg per 200 mL. Each mL contains 0.2 mg of Milrinone USP and 54.3 mg of dextrose. The medication comes in a sterile and nonpyrogenic container without any preservatives. It has to be used only if the solution is clear, colorless, or pale yellow, and the unused portion should be discarded. The package insert should be consulted for the usual dosage. The medication should be stored at room temperature, and protection from freezing should be taken. The overwrap maintains the sterility of the product. The medication is distributed by AuroMedics Pharma LLC.*

This is a description of Milrinone Lactate in 5% Dextrose Injection. It includes information such as the dosage, the contents of each mL of the solution, and the storage requirements. Additionally, it advises the user to discard the unused portion and check the container for leaks before use. It also warns not to administer simultaneously with blood and not to use if the overwrap has been previously opened or damaged. The solution comes in a sterile, non-pyrogenic, single-dose container and is distributed by PuroMedics Pharma LLC. Made in India.*